Dr. med. Gerald Wulf

 
Staff Status
unigoe
 

1-6 of 6
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2020 Journal Article
    ​ ​Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial​
    Beelen, D. W.; Trenschel, R.; Stelljes, M.; Groth, C.; Masszi, T.; Reményi, P. & Wagner-Drouet, E.-M. et al.​ (2020) 
    The Lancet Haematology7(1) pp. e28​-e39​.​ DOI: https://doi.org/10.1016/S2352-3026(19)30157-7 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT​
    Frankiewicz, A.; Peczynski, C.; Giebel, S.; Harrington, A.; Socié, G.; Niederwieser, D. & Scheid, C. et al.​ (2020) 
    Frontiers in Immunology11.​ DOI: https://doi.org/10.3389/fimmu.2020.01537 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey​
    Sellner, L.; Schetelig, J. ; Koster, L.; Choi, G.; Blaise, D.; Beelen, D. & Schianca, F. C. et al.​ (2020) 
    Bone Marrow Transplantation55(12) pp. 2335​-2338​.​ DOI: https://doi.org/10.1038/s41409-020-0946-x 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia​
    Michallet, M.; Dreger, P.; Sobh, M.; Koster, L.; Hoek, J.; Boumendil, A. & Scheid, C. et al.​ (2019) 
    Bone Marrow Transplantation55(5) pp. 884​-890​.​ DOI: https://doi.org/10.1038/s41409-019-0742-7 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Donor Lymphocyte Infusions for the Treatment of Relapsed Non-Hodgkin Lymphoma Following Allogeneic Stem Cell Transplantation: A LWP-EBMT Study​
    Robinson, S.; Boumendil, A.; Finel, H.; Khvedelidze, I.; Kanfer, E.; Peggs, K. & Furst, S. et al.​ (2018) 
    Blood132(Supplement 1) pp. 707​-707​.​ DOI: https://doi.org/10.1182/blood-2018-99-113906 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties​
    Dreger, P.; Michallet, M.; Bosman, P.; Dietrich, S.; Sobh, M.; Boumendil, A. & Nagler, A. et al.​ (2018) 
    Bone Marrow Transplantation54(1) pp. 44​-52​.​ DOI: https://doi.org/10.1038/s41409-018-0207-4 
    Details  DOI 

Publication List

Filter

Active filter:
Contributor:  Dreger, Peter

Type

Date issued

Author

Language

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp34512
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.